Notably, poly (ADP-ribose) polymerase inhibitors (PARPis) are DNA-damaging agents developed for cancer therapy, and USP15 has been shown to affect the response of cancer cells to PARPis by regulating HRR(Peng et al. 2019). This evidence concerns the gene USP15 and cancer.